{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T06:01:20Z","timestamp":1720072880775},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.imlet.2015.11.011","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T16:18:28Z","timestamp":1448381908000},"page":"41-51","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficient induction of cross-presentating human B cell by transduction with human adenovirus type 7 vector"],"prefix":"10.1016","volume":"169","author":[{"given":"Ying","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meimei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunyan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.imlet.2015.11.011_bib0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.it.2004.09.016","article-title":"DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy","volume":"25","author":"Schultze","year":"2004","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cellimm.2006.02.005","article-title":"B cells as antigen presenting cells","volume":"238","author":"Rodriguez-Pinto","year":"2005","journal-title":"Cell Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1365-2567.2007.02749.x","article-title":"CD40 ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides","volume":"124","author":"Ahmadi","year":"2008","journal-title":"Immunology"},{"key":"10.1016\/j.imlet.2015.11.011_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00005-008-0014-5","article-title":"The role of B lymphocytes as antigen-presenting cells","volume":"56","author":"Chen","year":"2008","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"key":"10.1016\/j.imlet.2015.11.011_bib0025","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.4049\/jimmunol.169.4.2164","article-title":"Efficient generation of antigen-specific cytotoxic T cells using retrovirally transduced CD40-activated B cells","volume":"169","author":"Kondo","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0030","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1182\/blood-2003-07-2379","article-title":"RNA-transfected CD40-activated B cells induce functional T-cell responses against viral and tumor antigen targets: implications for pediatric immunotherapy","volume":"103","author":"Coughlin","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2015.11.011_bib0035","first-page":"2836","article-title":"CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells","volume":"63","author":"Lapointe","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.imlet.2015.11.011_bib0040","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1002\/eji.200737758","article-title":"Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells","volume":"38","author":"Robson","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0045","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1084\/jem.180.5.1829","article-title":"A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4T cells but are inferior to dendritic cells in providing costimulation","volume":"180","author":"Cassell","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2015.11.011_bib0050","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.4049\/jimmunol.153.5.1990","article-title":"Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen","volume":"153","author":"Lenschow","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0055","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1084\/jem.179.5.1539","article-title":"Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells","volume":"179","author":"Ho","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2015.11.011_bib0060","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.4049\/jimmunol.1001869","article-title":"Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells","volume":"186","author":"Jiang","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0065","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/eji.200636984","article-title":"TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function","volume":"37","author":"Jiang","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0070","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","article-title":"Mechanism and function of a newly identified CpG DNA motif in human primary B cells","volume":"164","author":"Hartmann","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0075","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/eji.200323444","article-title":"CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides","volume":"33","author":"Gantner","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0080","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.169.2.787","article-title":"B cells capturing antigen conjugated with CpG oligodeoxynucleotides induce Th1 cells by elaborating IL-12","volume":"169","author":"Shirota","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0085","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4049\/jimmunol.172.3.1501","article-title":"CpG-DNA aided cross-priming by cross-presenting B cells","volume":"172","author":"Heit","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0090","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1128\/JVI.01926-06","article-title":"Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses","volume":"81","author":"Iacobelli-Martinez","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0095","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/hum.2007.016","article-title":"Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors","volume":"18","author":"Yamaguchi","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.imlet.2015.11.011_bib0105","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molimm.2012.02.119","article-title":"Adenovirus type 35, but not type 5, stimulates NK cell activation via plasmacytoid dendritic cells and TLR9 signaling","volume":"51","author":"Pahl","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0110","doi-asserted-by":"crossref","first-page":"6279","DOI":"10.1128\/JVI.00123-12","article-title":"The number of Toll-like receptor 9-agonist motifs in the adenovirus genome correlates with induction of dendritic cell maturation by adenovirus immune complexes","volume":"86","author":"Perreau","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0115","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/JVI.06181-11","article-title":"Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection","volume":"86","author":"Trinh","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/milmed\/160.6.300","article-title":"Adenovirus vaccines in the U.S. military","volume":"160","author":"Gaydos","year":"1995","journal-title":"Mil. Med."},{"key":"10.1016\/j.imlet.2015.11.011_bib0125","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.vaccine.2012.12.029","article-title":"History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (Adenovirus Vaccine) in the context of the Department of Defense acquisition system","volume":"31","author":"Hoke","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2015.11.011_bib0130","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2015.11.011_bib0135","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1016\/j.vaccine.2013.04.035","article-title":"A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits","volume":"31","author":"Kuschner","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2015.11.011_bib0140","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0264-410X(91)90033-3","article-title":"Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs","volume":"9","author":"Chengalvala","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.imlet.2015.11.011_bib0145","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/infdis\/166.4.769","article-title":"Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee","volume":"166","author":"Hsu","year":"1992","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.imlet.2015.11.011_bib0150","doi-asserted-by":"crossref","DOI":"10.4161\/hv.27238","article-title":"Vaccines within vaccines: the use of adenovirus types 4 and 7 as influenza vaccine vectors","volume":"10","author":"Weaver","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.imlet.2015.11.011_bib0155","first-page":"96","article-title":"Cloning and eukaryotic expression of adenovirus type 7 E1A gene","volume":"30","author":"Shen","year":"2008","journal-title":"Chin. J. Cell Biol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0160","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/JVI.70.7.4805-4810.1996","article-title":"Efficient generation of recombinant adenovirus vectors by homologous recombination in E. coli","volume":"70","author":"Chartier","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0166-0934(00)00280-9","article-title":"Rapid method for the isolation of full length adenoviral genomes by bacterial intermolecular homologous recombination","volume":"92","author":"Youil","year":"2001","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.imlet.2015.11.011_bib0170","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nprot.2007.135","article-title":"A protocol for rapid generation of recombinant adenoviruses using the AdEasy system","volume":"2","author":"Luo","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.imlet.2015.11.011_bib0175","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2249.2005.02733.x","article-title":"Ex vivo induction of viral antigen-specific CD8T cell responses using mRNA-electroporated CD40-activated B cells","volume":"139","author":"Van den Bosch","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-005-0988-1","article-title":"Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2\/neu vaccine peptides","volume":"92","author":"Mittendorf","year":"2005","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.imlet.2015.11.011_bib0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imlet.2015.11.011_bib0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4933-10-3","article-title":"Increased activation and cytokine secretion in B cells stimulated with leptin in aged humans","volume":"10","author":"Gupta","year":"2013","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.imlet.2015.11.011_bib0195","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.4049\/jimmunol.178.10.6092","article-title":"Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis","volume":"178","author":"Duddy","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0200","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1189\/jlb.0908560","article-title":"IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production","volume":"86","author":"Giordani","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0205","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1073\/pnas.0510965103","article-title":"Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses","volume":"103","author":"Chi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.imlet.2015.11.011_bib0210","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00262-008-0533-2","article-title":"Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus","volume":"58","author":"Vujanovic","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.imlet.2015.11.011_bib0215","doi-asserted-by":"crossref","first-page":"e10192","DOI":"10.1371\/journal.pone.0010192","article-title":"Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells","volume":"5","author":"Suarez-Alvarez","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2015.11.011_bib0220","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/leu.2008.391","article-title":"In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray","volume":"23","author":"Hoves","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.imlet.2015.11.011_bib0225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/erv.10.49","article-title":"New flow cytometric assays for monitoring cell-mediated cytotoxicity","volume":"9","author":"Zaritskaya","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.imlet.2015.11.011_bib0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jim.2007.08.005","article-title":"Use of the CD107 mobilization assay reveals that cytotoxic T lymphocytes with novel MHC-Ib restriction are activated during Listeria monocytogenes infection","volume":"328","author":"McElroy","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.imlet.2015.11.011_bib0235","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1479-5876-9-122","article-title":"Cytotoxic T lymphocyte responses against melanocytes and melanoma","volume":"9","author":"Chang","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.imlet.2015.11.011_bib0240","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4049\/jimmunol.131.1.109","article-title":"B cells as antigen-presenting cells: the requirement for B cell activation","volume":"131","author":"Kakiuchi","year":"1983","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0245","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1084\/jem.160.4.1102","article-title":"Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors","volume":"160","author":"Rock","year":"1984","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2015.11.011_bib0250","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/314537a0","article-title":"Antigen-specific interaction between T and B cells","volume":"314","author":"Lanzavecchia","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2015.11.011_bib0255","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F","volume":"72","author":"Roelvink","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0260","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1128\/JVI.64.8.3661-3673.1990","article-title":"Human adenovirus\u2013host cell interactions: comparative study with members of subgroups B and C","volume":"64","author":"Defer","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0265","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus receptors","volume":"79","author":"Zhang","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0270","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.imlet.2015.11.011_bib0275","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virusres.2006.07.009","article-title":"Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors","volume":"122","author":"Short","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.imlet.2015.11.011_bib0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/viro.1999.9864","article-title":"Cellular uptake and nuclear delivery of recombinant adenovirus penton base","volume":"262","author":"Hong","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.imlet.2015.11.011_bib0285","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","article-title":"Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus","volume":"202","author":"Barrat","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.imlet.2015.11.011_bib0290","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1182\/blood.V99.2.600","article-title":"Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions","volume":"99","author":"Lyakh","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2015.11.011_bib0295","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1128\/JVI.74.20.9617-9628.2000","article-title":"Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway","volume":"74","author":"Morelli","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0300","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/JVI.75.3.1387-1400.2001","article-title":"Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein","volume":"75","author":"Miyazawa","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0305","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1128\/JVI.77.6.3712-3723.2003","article-title":"The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses","volume":"77","author":"Shayakhmetov","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.imlet.2015.11.011_bib0310","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.4049\/jimmunol.1402690","article-title":"TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics","volume":"194","author":"Simchoni","year":"2015","journal-title":"J. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247815300699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T23:28:37Z","timestamp":1692142117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247815300699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":62,"alternative-id":["S0165247815300699"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2015.11.011","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient induction of cross-presentating human B cell by transduction with human adenovirus type 7 vector","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2015.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}